ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #7,395Hybrid

Saudi Pharmaceutical Journal

Acronym:spj
•
Abbreviation (ISO):SAUDI PHARM J
•
Identifier (ISSN):1319-0164(Print)
•
Publisher:King Saud University
Clarivate IF (2026)
4.3↑ +0.9
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Saudi Pharmaceutical Journal

WoS Q2
23563.1120183.6420192.8820204.3320214.5620224.12023320243.420254.32026
Annual Impact Factor Metric
Current (2026):4.3
Scopus SJR & RankScopus Q2
0.762
#7,395

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
91

91 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate3.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
164articles/year
99.48% Gold OA•88.77% Original Research

Aims & Scope

The Saudi Pharmaceutical Journal (SPJ) is the official journal of the Saudi Pharmaceutical Society (SPS) publishing high quality clinically oriented submissions which encompass the various disciplines of pharmaceutical sciences and related subjects. SPJ publishes 8 issues per year by the Saudi Pharmaceutical Society, with the cooperation of the College of Pharmacy, King Saud University.

Topics Covered (Recognized by AI)
Medicine86%Biology83.9%Chemistry64.4%Internal medicine57.3%Biochemistry53.1%Pharmacology46.7%Organic chemistry45.6%Genetics43.6%Physics37.2%Psychology35.9%Pathology33.8%Psychiatry27.8%Engineering26.5%Endocrinology24.8%Mathematics22.1%Materials science21.8%Chromatography21.5%Family medicine20.3%Nursing20.2%Law20.2%Political science20.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank95/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank81/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.3
Articles / Year58
Total Citations31
2025
IF3.4
Articles / Year54
Total Citations186
2024
IF3
Articles / Year184
Total Citations1,546
2023
IF4.1
Articles / Year347
Total Citations4,127
2022
IF4.562
Articles / Year216
Total Citations3,312

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,395Scopus Q2SCImago Profile
Scopus Coverage:1996-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.762

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
4.96

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,080 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,419
3-Year Documents720
Citable Documents713

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ2
PharmacologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Saudi Pharmaceutical Journal (acronym: spj, abbr: SAUDI PHARM J, ISSN: 1319-0164) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by King Saud University in Saudi Arabia since 1993. The periodical holds a Journal Impact Factor (JIF) of 4.30, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.762 (Q2), an H-index of 91.

The journal enforces rigorous peer evaluation with an annual output of approximately 164 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,080 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
King Saud University
Publication Language
English
Frequency
Periodic
Founding Year
1993
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f5e902ea-ea9d-495e-bb76-01e0046db629
Database Updated: 2026-10-16